Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck.
about
In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancerBiweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck.Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329.
P2860
Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Phase II Study of Gemcitabine ...... arcinoma of the Head and Neck.
@ast
Phase II Study of Gemcitabine ...... arcinoma of the Head and Neck.
@en
type
label
Phase II Study of Gemcitabine ...... arcinoma of the Head and Neck.
@ast
Phase II Study of Gemcitabine ...... arcinoma of the Head and Neck.
@en
prefLabel
Phase II Study of Gemcitabine ...... arcinoma of the Head and Neck.
@ast
Phase II Study of Gemcitabine ...... arcinoma of the Head and Neck.
@en
P2093
P2860
P356
P1433
P1476
Phase II Study of Gemcitabine ...... arcinoma of the Head and Neck.
@en
P2093
Ammar Sukari
Daryn Smith
George Yoo
Heather Mulrenan
Ho-Sheng Lin
John Jacobs
Lance K Heilbrun
Omer Kucuk
Zyad Kafri
P2860
P304
P356
10.5402/2012/159568
P577
2012-05-10T00:00:00Z